What is CBT-I (Cognitive-Behavioral Therapy for Insomnia)?
CBT-I is a multicomponent, structured psychological treatment for chronic insomnia that combines behavioral techniques (sleep restriction and stimulus control) with cognitive strategies to address the perpetuating factors that maintain insomnia, typically delivered over 4-8 sessions. 1
Core Components
CBT-I integrates several evidence-based elements that work synergistically:
Behavioral Interventions
Sleep Restriction Therapy: Limits time in bed to match actual sleep duration (calculated from sleep diaries), then gradually adjusts based on sleep efficiency thresholds. This enhances sleep drive and consolidates fragmented sleep 1, 2
Stimulus Control Instructions: Re-associates the bed/bedroom with sleep by implementing five specific rules:
Cognitive and Educational Components
Cognitive Therapy: Identifies and restructures unhelpful beliefs about sleep through psychoeducation, Socratic questioning, thought records, and behavioral experiments 1, 2
Sleep Hygiene Education: Addresses lifestyle factors (diet, exercise, substance use) and environmental conditions (light, noise, temperature) that affect sleep 1, 2
Relaxation Training: Reduces somatic tension (progressive muscle relaxation, breathing exercises) and cognitive arousal (guided imagery, meditation) 1, 2
Treatment Structure
CBT-I typically involves 4-8 sessions with ongoing sleep diary monitoring to track progress and adjust interventions 1, 2. Brief versions (BTIs) condense this to 1-4 sessions, emphasizing behavioral components 1.
Clinical Effectiveness
The American Academy of Sleep Medicine (2021) strongly recommends CBT-I as the preferred first-line treatment for chronic insomnia disorder based on moderate-quality evidence showing 1:
- Clinically significant improvements in sleep quality, sleep latency, and wake after sleep onset
- Remission and responder rates superior to control conditions
- Durable long-term benefits without need for ongoing intervention
- Effectiveness across populations: works for insomnia with no comorbidities, psychiatric comorbidities, and medical comorbidities 1
Important Clinical Considerations
Contraindications and Precautions
Sleep restriction therapy may be contraindicated in 1:
- Heavy machinery operators or professional drivers (due to temporary increased daytime sleepiness)
- Patients predisposed to mania/hypomania
- Poorly controlled seizure disorders
Expected Side Effects
Early treatment may cause temporary symptoms that resolve by end of treatment 1:
- Daytime fatigue and sleepiness
- Mood impairment (irritability)
- Cognitive difficulties (attention problems)
These effects are restricted to the initial behavioral therapy phase and improve as treatment progresses.
Advantages Over Pharmacotherapy
CBT-I produces superior long-term effectiveness with minimal side effects compared to sleep medications 1. Key advantages include:
- Sustained benefits without ongoing treatment
- No risk of tolerance or dependence
- May reduce or eliminate need for hypnotic medications
- Addresses root perpetuating factors rather than just symptoms 3, 4
The cost-effectiveness is favorable despite higher initial time investment, given that insomnia is time-limited treatment and untreated chronic insomnia carries significant healthcare costs 1.